This is a tiered framework: test first, supplement for confirmed deficiencies or increased demand, and insist on third-party quality certification. The top tier has real RCT meta-analyses, including vitamin D3 cutting all-cause mortality 6% across 56 trials and omega-3 cutting MI risk 28% in VITAL, while condition-specific and longevity tiers get progressively thinner. Some popular products are actively harmful, such as high-dose beta-carotene in smokers and iron taken without testing.
Summary drafted from this entry’s sources; editorial review pending.
01Key questions
Which supplements have the strongest evidence?
Vitamin D3 (all-cause mortality down 6% in a 56-trial Cochrane meta-analysis of 95,286 people; cancer mortality down 15% in a BMJ meta-analysis), omega-3 fatty acids (28% lower MI risk in VITAL, 25% fewer cardiovascular events in REDUCE-IT), creatine, and magnesium. Berberine, curcumin and inositol sit a tier below for specific conditions.1256
Do omega-3 supplements prevent heart disease?
The evidence is genuinely mixed: VITAL (n=25,871) found a 28% MI reduction and REDUCE-IT (n=8,179) found 25% fewer cardiovascular events with purified EPA, but the STRENGTH trial of high-dose EPA+DHA found no benefit and a possible atrial-fibrillation signal. Mechanism and dose differences between the trials matter.567
Which supplements should be avoided?
The entry's caution list: high-dose beta-carotene (increased lung cancer in smokers), high-dose vitamin E (all-cause mortality signal in meta-analyses), calcium carbonate without vitamin K2, iron without testing, St. John's Wort (major CYP450 interactions), kava (hepatotoxicity), chronic high-dose B6, and most testosterone boosters.7
Are supplements what their labels claim?
Often not. The industry is largely unregulated, third-party certification programs (NSF, USP, GMP, ConsumerLab) exist because mislabeling is common, and proprietary blends can hide actual doses.
Supplements should fill gaps in an optimal diet, not compensate for a poor one. The supplement industry is largely unregulated and full of overpriced, under-dosed, and sometimes dangerous products. However, a targeted supplement stack based on individual testing and evidence can meaningfully improve health outcomes.
02Critical Framework for Supplementation
When Supplements Make Sense
- Nutrient deficiency confirmed by testing (vitamin D, B12, iron, magnesium)
- Increased physiological demand (pregnancy, intense training, chronic illness)
- Food supply inadequacy (soil depletion makes some nutrients harder to obtain)
- Therapeutic dosing for specific conditions (niacin for lipids, berberine for blood sugar)
- Constitutional enhancement (creatine for muscle, omega-3 for inflammation)
When Supplements Don't Make Sense
- To "fix" a bad diet — supplements cannot replicate whole-food matrices
- Based on marketing, not evidence — most supplement marketing is hype
- "Kitchen sink" approaches — throwing 30 supplements at a wall
- Without measuring — don't supplement what you haven't tested
- Expecting drugs-level effects — supplements are subtle, food-grade interventions
Quality Matters
- Third-party testing: Look for NSF, USP, GMP, or ConsumerLab certification
- Bioavailable forms: Glycinate > oxide (magnesium), methylcobalamin > cyanocobalamin (B12), ubiquinol > ubiquinone (CoQ10)
- Avoid: Proprietary blends (hiding doses), unnecessary fillers, artificial colors
03Tier 1: Strong Evidence (Most People Should Consider)
Vitamin D3
- Deficiency prevalence: ~40% of US population; higher in dark-skinned individuals, elderly, northern latitudes
- Optimal range: 40-60 ng/mL (100-150 nmol/L)
- Cofactors: Vitamin K2 (MK-7, 100-200 mcg), magnesium (required for activation)
- Evidence: Immune function, bone health, mood, hormone synthesis
- Mortality evidence (2024 update): Cochrane 2014 meta-analysis of 56 RCTs (n=95,286) — vitamin D3 ↓ all-cause mortality (RR 0.94, 95% CI 0.91–0.98; PMID 24414552). Zhang 2019 BMJ meta-analysis (50 trials, n=74,655) — vitamin D3 ↓ cancer mortality 15% (RR 0.85, 95% CI 0.74–0.97; PMID 31405892). 2024 RCT meta-analysis (COVID-19, 19 RCTs, n=2,495) — ↓ all-cause mortality OR 0.72 (95% CI 0.53–0.98; severe COVID OR 0.57, 95% CI 0.35–0.92). Vitamin D2, alfacalcidol, and calcitriol showed no mortality benefit. PMID-summarized in umbrella review (Suzuki 2023, 116 RCTs, n=149,865): respiratory cancer ↓ (RR 0.56), COVID-19 ↓ (RR 0.54), liver cirrhosis ↓ (RR 0.63); no benefit in general healthy, CKD, CVD, sepsis populations.
Magnesium
- Deficiency prevalence: ~50% of US population gets less than RDA
- Why we're deficient: Soil depletion, water treatment, stress depletes Mg, prescription drugs
- Best forms: Glycinate (sleep/calm), threonate (brain), malate (energy), citrate (bowels)
- Functions: 300+ enzymatic reactions, ATP production, muscle relaxation, sleep, DNA repair
- Key evidence: Rosanoff A et al. 2012, Nutr Rev / Mg Res — "Essential Role of Magnesium in Human Health" (PMID 22389183) — foundational review of deficiency burden and metabolic sequelae. Fang X et al. 2016, BMC Med — meta-analysis of 40 prospective cohort studies; ↑ dietary magnesium ↓ risk of stroke, heart failure, T2D, and all-cause mortality (PMID 26912566). Veronese N et al. 2019, Eur J Clin Nutr — meta-analysis: magnesium supplementation ↓ systolic BP (−2.00 mmHg) and ↑ flow-mediated dilation in hypertensive/older subjects.
Omega-3 Fatty Acids (EPA/DHA)
- Rationale: Omega-6 excess in modern diet requires omega-3 compensation
- Sources: Fish oil, algae oil (vegan), krill oil
- Quality: Must be third-party tested for oxidation, heavy metals
- Evidence: Cardiovascular protection, anti-inflammatory, brain health, mood
- Key evidence: VITAL trial (Manson JE et al. 2019, NEJM 380:33–44, PMID 30415637; n=25,871) — omega-3 ↓ MI risk 28% (HR 0.72, 95% CI 0.59–0.90), with stronger effect in low fish-intake subgroup. REDUCE-IT trial (Bhatt DL et al. 2019, NEJM 380:11–22, PMID 30415628; n=8,179) — icosapent ethyl 4g/day ↓ CV events 25% (HR 0.75, 95% CI 0.68–0.83); mineral oil placebo caveat. STRENGTH trial (Nicholls SJ et al. 2020, JAMA 324:2268–2280, PMID 33190147) — high-dose EPA+DHA + mineral oil placebo, no benefit, possibly pro-arrhythmic in atrial fibrillation subgroup. Mechanism + dose-response differences between trials are key.
Creatine
- Not just for bodybuilders: Cognitive benefits well-established; neuroprotection
- Form: Creatine monohydrate (cheapest and best-studied; all other forms are inferior)
- Evidence: Strength, power, brain energy, traumatic brain injury recovery, aging
- Deep dive: Creatine Monohydrate - Muscle, Brain, and Bone Evidence — full evidence taxonomy (2024-26 cognition/depression/menopause trials), dosing protocols, safety analysis
04Tier 2: Condition-Specific Evidence
Metabolic Health
| Supplement | Use Case | Evidence |
|---|---|---|
| Berberine | Blood sugar, insulin sensitivity (comparable to metformin) | Strong |
| Alpha-lipoic acid | Insulin sensitizer, neuropathy, antioxidant | Moderate-strong |
| Chromium picolinate | Glucose metabolism | Moderate |
| Inositol | PCOS, insulin signaling, mood | Strong (PCOS) |
Swipe table →
Anti-Inflammatory
| Supplement | Use Case | Evidence |
|---|---|---|
| Curcumin (with piperine/liposomal) | Systemic inflammation, joint pain | Strong |
| Boswellia serrata | Joint inflammation, gut inflammation | Moderate |
| Quercetin | Allergies, senolytic, antioxidant | Moderate |
| Ginger | Digestive, anti-inflammatory | Moderate |
Swipe table →
Cognitive/Nootropic
| Supplement | Use Case | Evidence |
|---|---|---|
| Lion's Mane | NGF stimulation, cognitive support | Moderate (see Lion's Mane and Mushroom Nootropics) |
| L-theanine | Calm focus, pairs with caffeine | Moderate |
| Phosphatidylserine | Memory, stress response | Moderate |
| Bacopa monnieri | Memory consolidation | Moderate |
Swipe table →
Sleep and Recovery
| Supplement | Use Case |
|---|---|
| Magnesium glycinate | Sleep quality |
| Glycine | Core temperature, sleep quality |
| GABA | Relaxation (blood-brain barrier penetration debated) |
| 5-HTP | Serotonin precursor (caution with SSRIs) |
Swipe table →
05Tier 3: Emerging/Advanced
Longevity-Related
- NAD+ precursors (NMN, NR): See NAD+ and Sirtuin Activators
- Urolithin A: Mitophagy induction; pomegranate-derived
- Spermidine: Autophagy inducer; found in wheat germ, aged cheese
- Fisetin: Senolytic compound; found in strawberries
- Resveratrol: SIRT1 activator; bioavailability issues
- Alpha-Ketoglutarate (CaAKG): See Alpha-Ketoglutarate (AKG) - The Metabolic Longevity Molecule — TCA cycle metabolite; ~12% mouse lifespan extension; top supplement for biological age reduction in 2026 observational study of 84 compounds (PMID 42166733)
06Supplements to Avoid or Approach with Caution
| Supplement | Issue |
|---|---|
| High-dose beta-carotene | Increased lung cancer risk in smokers |
| High-dose vitamin E | Increased all-cause mortality in meta-analyses |
| Calcium carbonate alone | Cardiovascular risk without K2; poor absorption |
| Iron (without testing) | Iron overload is as dangerous as deficiency |
| St. John's Wort | Massive drug interactions (CYP450 inducer) |
| Kava | Hepatotoxicity risk |
| High-dose B6 | Peripheral neuropathy with chronic high doses |
| Most "testosterone boosters" | Herbal blends with no evidence of T elevation |
Swipe table →
07Connections
08Sources
- Bjelakovic G et al. (2014). Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev CD007470. PMID 24414552 — 56 RCTs, n=95,286; vitamin D3 ↓ all-cause mortality (RR 0.94).PubMed 24414552
- Zhang Y et al. (2019). Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ 366:l4673. PMID 31405892 — 50 RCTs, n=74,655; vitamin D3 ↓ cancer mortality 15% (RR 0.85).PubMed 31405892
- PubMed 22389183PubMed 22389183
- Fang X et al. (2016). Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med 14:210. PMID 26912566 — 40 prospective cohorts.PubMed 26912566
- Manson JE et al. (VITAL trial). (2019). Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. NEJM 380:33–44. PMID 30415637 — n=25,871; omega-3 ↓ MI risk 28%.PubMed 30415637
- Bhatt DL et al. (REDUCE-IT). (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. NEJM 380:11–22. PMID 30415628 — n=8,179; icosapent 4g/day ↓ CV events 25%.PubMed 30415628
- Nicholls SJ et al. (STRENGTH). (2020). Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. JAMA 324:2268–2280. PMID 33190147 — null result, AF risk signal.PubMed 33190147
- PubMed 42166733PubMed 42166733
- Rosanoff A, Weaver CM, Rude RK. (2012). Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 70(3):153–164. PMID 22389157 — foundational Mg deficiency burden review.PubMed 22389157
- Suzuki M et al. (2023). The effects of vitamin D on all-cause mortality in different diseases: an evidence-map and umbrella review of 116 randomized controlled trials. Front Nutr 10:1132528. PMC10325578 — umbrella review; benefits limited to respiratory cancer, COVID-19, liver disease subgroups.PMC10325578
09Entry history
Latest content update.
Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.